First Manhattan’s Dynavax Technologies DVAX Stock Holding History

First Manhattan’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-2,000	Closed	-$49K	–	1430
2015 Q3	$49K	Buy	+2,000	New	+$56.6K	﹤0.01%	942

Other funds holding DVAX

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

First Manhattan's DVAX Position: Q4 2015 in Review

First Manhattan sold out of Dynavax Technologies (DVAX) in Q4 2015, closing a stake of 2,000 shares — an estimated $49K sold.

First Manhattan first reported a position in DVAX in Q3 2015 and held it in 1 quarter. The position peaked at $49K in Q3 2015. 152 funds tracked by Wall St. Rank hold DVAX as of Q4 2015.

First Manhattan reported no remaining Dynavax Technologies position as of Q4 2015 after selling out during the quarter.
First Manhattan sold 2,000 Dynavax Technologies shares in Q4 2015, an estimated $49K.
First Manhattan first reported a position in Dynavax Technologies in Q3 2015 and held it in 1 quarter.
First Manhattan's Dynavax Technologies position peaked at $49K in Q3 2015.
152 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2015.

Based on First Manhattan's 13F filing for Q4 2015, filed 20 Jan 2016.